Patent details

Basic Information

Publication number:

EP3313818

PCT Application Number:

US2016039245

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP168153757

PCT Publication Number:

WO2016210262

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS FOR THE TREATMENT OF KAPOSI'S SARCOMA OR KSHV-INDUCED LYMPHOMA USING IMMUNOMODULATORY COMPOUNDS, AND USES OF BIOMARKERS

French Title of Invention:

PROCÉDÉS POUR LE TRAITEMENT DU SARCOME DE KAPOSI OU LE LYMPHOME INDUIT PAR LE KSHV À L'AIDE DE COMPOSÉS IMMUNOMODULATEURS ET UTILISATIONS DE BIOMARQUEURS

German Title of Invention:

VERFAHREN ZUR BEHANDLUNG VON KAPOSI-SARKOM ODER KSVH-INDUZIERTEM LYMPHOM UNTER VERWENDUNG IMMUNMODULATORISCHER VERBINDUNGEN UND VERWENDUNGEN VON BIOMARKERN

SPC Number:

Dates

Filing date:

24/06/2016

Grant date:

08/11/2023

EP Publication Date:

02/05/2018

PCT Publication Date:

29/12/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/11/2023

EP B1 Publication Date:

08/11/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

24/06/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/01/2024

 

 

Name:

Celgene Corporation

Address:

Route 206 & Province Line Road, Princeton, NJ 08543, United States (US)

Name:

The U.S.A. as represented by the Secretary, Department of Health and Human Services

Address:

Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325 MSC 7660, Bethesda, MD 20892-7660, United States (US)

History of Owners

From:

01/11/2023

To:

19/01/2024

Name:

Celgene Corporation

Address:

86 Morris Avenue, Summit, NJ 07901, United States (US)

Name:

The U.S.A. as represented by the Secretary, Department of Health and Human Services

Address:

Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325 MSC 7660, Bethesda, MD 20892-7660, United States (US)

Agent

Name:

VALIPAT

From:

04/12/2023

Address:

Avenue Louise 54, 1050, Bruxelles, Belgium (BE)

To:

Inventor

1

Name:

YARCHOAN, Robert

Address:

United States (US)

2

Name:

WHITBY, Denise

Address:

United States (US)

3

Name:

ULDRICK, Thomas

Address:

United States (US)

4

Name:

DAVIS, David

Address:

United States (US)

5

Name:

POLIZZOTTO, Mark

Address:

Australia (AU)

6

Name:

SERETI, Irini

Address:

United States (US)

7

Name:

KHETANI, Vikram

Address:

United States (US)

8

Name:

ZELDIS, Jerome

Address:

United States (US)

Priority

Priority Number:

201562185265 P

Priority Date:

26/06/2015

Priority Country:

United States (US)

Classification

IPC classification:

C07D 209/48; A61K 31/404; A61K 45/06; C07D 471/04; C07D 473/34; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:

202345

Publication date:

08/11/2023

Description:

Grant (B1)

2

Issue number:

202408

Publication date:

21/02/2024

Description:

Change of owner's name or address

Deed

Power of attorney

Change Kind/ Decision Type:

Assignment

Deed Number:

RC20230000503A

Date Registered:

04/12/2023

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

VALIPAT

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

30/06/2026

Annual Fee Number:

11

Annual Fee Amount:

148 Euro

Expected Payer:

Last Annual Fee Payment Date:

11/06/2025

Last Annual Fee Paid Number:

10

Last Annual Fee Paid Amount:

131 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
11/01/2024	Incoming Correspondence (Post)	1
04/12/2023	Request For Change	2
04/12/2023	Outgoing Correspondence	2
13/03/2026	Request For Change	5
16/03/2026	Outgoing Correspondence	46